Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Hypertensive disorders of pregnancy affect approximately one in ten pregnancies and often persist postpartum. Their postnatal course can be unpredictable and complications may occur, hence control remains important but is informed by little evidence. Clinicians from UK primary and secondary healthcare were invited to complete a survey regarding antihypertensive adjustment postpartum. The response rate was 101/390 (26%). Labetalol was the commonest antihypertensive used. Most participants reported following national guidelines when reducing, although not increasing, antihypertensive medications. The results suggest an unwarranted and unjustifiable variation in management - underlining the evidence gap - additional research is needed to inform the standardisation of care.

Original publication

DOI

10.1016/j.preghy.2016.08.240

Type

Journal article

Journal

Pregnancy Hypertens

Publication Date

10/2016

Volume

6

Pages

256 - 258

Keywords

Antihypertensive medication, Gestational hypertension, Postpartum, Pre-eclampsia, Pregnancy, Survey, Antihypertensive Agents, Blood Pressure, Female, General Practice, Guideline Adherence, Humans, Hypertension, Pregnancy-Induced, Labetalol, Midwifery, Obstetrics, Postpartum Period, Practice Guidelines as Topic, Practice Patterns, Physicians', Pregnancy, Surveys and Questionnaires